Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Diabetes Treatment and Management, Pancreatic function and diabetes, Diabetes, Cardiovascular Risks, and Lipoproteins, and Diabetes Management and Research.
Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study
Impact of <scp>MASLD</scp> and <scp>MetALD</scp> on clinical outcomes: A meta‐analysis of preliminary evidence
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis
Precision stratification of prognostic risk factors associated with outcomes in gestational diabetes mellitus: a systematic review
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
Precision treatment of beta-cell monogenic diabetes: a systematic review
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Precision subclassification of type 2 diabetes: a systematic review
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
Precision gestational diabetes treatment: a systematic review and meta-analyses
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review
Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study
The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history
Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes
Prevalence and impact of diabetes among people infected with SARS-CoV-2
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration